West-Ward, the U.S. division of Hikma Pharmaceuticals, announced the availability of Mitigare (colchicine) capsules and its authorized generic for the prophylaxis of gout flares in adults. Colchicine ...
Overview: Colchicine tablets, capsules, and liquid are used to reduce complications from coronary artery disease, treat Familial Mediterranean Fever, and treat or prevent gout attacks. The most common ...
London, 10 October 2014 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that the United States ...
Colchicine oral tablet is available as both a generic and brand-name drug. Brand name Colcrys. It also comes in capsules that are also available as both a generic and brand-name drug. Brand name: ...
Colchicine, a generic prescription tablet used for gout and familial Mediterranean fever (FMF), can cause side effects. These can include mild side effects such as diarrhea and nausea. Or they can ...
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Tuesday said it was granted approval by the US Food and Drug Administration for its colchicine 0.6mg capsules for prophylaxis of gout flares in ...
London, 30 September 2014 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces the approval of its ...
Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda") has ...
Colchicine comes as an oral tablet that you swallow. It’s available in one strength: 0.6 milligrams (mg). Colchicine oral tablet also comes in the brand name version Colcrys. Other brand-name versions ...
London, 10 October 2014 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that the United States ...
Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda") has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results